At the end of the first quarter of 2013, Merck had 38,311 employees worldwide, compared to 38,847 on December 31, 2012.
Merck Group | Number of employees as of March 31: 38,311
From a regional perspective, the Emerging Markets region, which comprises Latin America and Asia excluding Japan, generated the strongest organic sales growth, expanding sales by 11.5% to € 924 million (Q1 2012: € 845 million). This increase was due especially to the performance of the Merck Serono and Performance Materials divisions. The proportion of Group sales accounted for by this region thus increased to 35% (Q1 2012: 33%). In North America, sales grew organically by 5.6% to € 516 million (Q1 2012: € 487 million), with Merck Serono and Merck Millipore driving the increase. This region’s share of Group sales remained unchanged at 19%. In Europe, sales totaled € 1,013 million (Q1 2012: € 1,000 million). Organic sales growth amounted to 1.0% and was primarily attributable to the Consumer Health division. Europe’s share of Group sales decreased slightly to 38% (Q1 2012: 39%). Lastly, the Rest of World region recorded an organic sales decline of 2.4% to € 207 million (Q1 2012: € 233 million) as a result of weaker demand in the Performance Materials and Merck Millipore divisions. This region’s contribution to Group sales fell slightly to 8% (Q1 2012: 9%).
| XLS |
|
Merck Group | Growth components by region – Q1 2013 | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ million/change in % |
Sales |
Organic growth |
Exchange rate effects |
Acquisitions/ |
Reported |
|
Europe |
1,012.9 |
1.0% |
– |
0.3% |
1.3% |
|
North America |
516.0 |
5.6% |
0.4% |
– |
6.0% |
|
Emerging Markets |
924.1 |
11.5% |
–2.1% |
– |
9.4% |
|
Rest of World |
207.3 |
–2.4% |
–8.5% |
– |
–10.8% |
|
Group |
2,660.4 |
5.0% |
–1.4% |
0.1% |
3.8% |
Merck Group | Sales by region – Q1 2013
search hit 05
